Effects of short-term inhaled fluticasone on oxidative burst of sputum cells in cystic fibrosis patients

European Respiratory Journal

Volumn 14, Issue 5, 1999, Pages 1150-1155

  Dauletbaev, N ^a   Viel, K ^a   Behr, J ^b   Loitsch, S ^a   Buhl, R ^c   Wagner, T O F ^a   Bargon, J ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Corticosteroids; Cystic fibrosis; Induced sputum; Oxidative burst

Indexed keywords

FLUTICASONE; MYELOPEROXIDASE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG EFFECT; FEMALE; HUMAN; INFLAMMATION; INFLAMMATORY CELL; INHALATIONAL DRUG ADMINISTRATION; LEUKOCYTE COUNT; LUNG FUNCTION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY BURST; SPUTUM ANALYSIS;

EID: 0032721113     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.99.14511509     Document Type: Article

References (26)

1. Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med 1996; 154: 1229-1256.
2. Pilewski JM, Frizzell RA. Role of CFTR in airway disease. Physiol Rev 1999; 79: S215-S255.
3. Barnes PJ. Current issues for establishing inhaled corticosteroids as the anti-inflammatory agents of choice in asthma. J Allergy Clin Immunol 1998; 101: S427-S433.
4. Boushey HA. Effects of inhaled corticosteroids on the consequences of asthma. J Allergy Clin Immunol 1998; 102 (Pt 2): S5-S16.
5. Balfour-Lynn IM, Klein NJ, Dinwiddle R. Randomized controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis. Arch Dis Child 1997; 77: 124-130.
6. Bisgaard H, Pedersen SS, Nielsen KG, et al. Controlled trial of inhaled budesonide in patients with cystic fibrosis and chronic bronchopulmonary Pseudomonas aeruginosa infection. Am J Respir Crit Care Medr 1997; 156: 1190-1196.
7. Nikolaizik WH, Schöni MH. Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis. J Pediatr 1996; 128: 271-274.
8. van Haren EHJ, Lammers J-WJ, Festen J, Heijerman HGM, Groot CAR, van Herwaarden CL. The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis. Respir Med 1995; 89: 209-214.
9. Buhl R, Jaffe HA, Holroyd KJ, et al. Activation of alveolar macrophages in asymptomatic HIV infected individuals. J Immunol 1993; 150: 1019-1028.
10. - production by human neutrophils. The preparation and assay of NADPH oxidase-containing particles from human neutrophils. Methods Enzymol 1984; 105: 358-365.
11. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 1983; 132: 345-352.
12. Eigen H, Rosenstein BJ, FitzSimmons S, Schidlow DV. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. J Pediatr 1995; 126: 515-523.
13. de la Fuente PT, Romagnoli M, Godard P, Bosquet J, Chanez P. Safety of inducing sputum in patients with asthma of varying severity. Am J Respir Crit Care Med 1998; 157: 1127-1130.
14. Conway SP, Watson A. Nebulized bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis. Thorax 1997; 52: S64-S68.
15. Barnes PJ, Adcock IM. Transcriptional factors and asthma. Eur Respir J 1998; 12: 221-234.
16. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med 1998; 157: S1-S53.
17. van der Velden VH. Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma. Mediators Inflamm 1998; 7: 229-237.
18. Leech M, Hutchinson P, Holdsworth SR, Morand EF. Endogenous glucocorticoids modulate neutrophil migration and synovial P-selectin but not neutrophil phagocytic or oxidative function in experimental arthritis. Clin Exp Immunol 1998; 112: 383-388.
19. Llewellyn-Jones CG, Hill SL, Stockley RA. Effect of fluticasone propionate on neutrophil chemotaxis, superoxide generation, and extracellular proteolytic activity in vitro. Thorax 1994; 49: 207-212.
20. Salmon M, Koto H, Lynch OT, et al. Proliferation of airway epithelium after ozone exposure: effect of apocynin and dexamethasone. Am J Respir Crit Care Med 1998; 157: 970-977.
21. Confalonieri M, Mainardi E, Della Porta R, et al. Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. Thorax 1998; 53: 583-585.
22. Tsang KW, Ho PL, Lam WK, et al. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. Am J Respir Crit Care Med 1998; 158: 723-727.
23. Tager AM, Wu J, Vermeulen MW. The effect of chloride concentration on human neutrophil functions: potential relevance to cystic fibrosis. Am J Respir Cell Mol Biol 1998; 19: 643-652.
24. Keatings VM, Jatakanon A, Worsdell YM, Barnes PJ. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155: 542-548.
25. Frühwirth M, Ruedl C, Ellemunter H, Böck G, Wolf H. Flow-cytometric evaluation of oxidative burst in phagocytic cells of children with cystic fibrosis. Int Arch Allergy Immunol 1998; 117: 270-275.
26. Jensen ET, Kharazmi A, Hoiby N, Costerton JW. Some bacterial parameters influencing the neutrophil oxidative burst response to Pseudomonas aeruginosa biofilms. APMIS 1992; 100: 727-733.